Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovix (ENVX) Common Equity (2020 - 2025)

Historic Common Equity for Enovix (ENVX) over the last 6 years, with Q3 2025 value amounting to $297.1 million.

  • Enovix's Common Equity rose 7451.8% to $297.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $297.1 million, marking a year-over-year increase of 7451.8%. This contributed to the annual value of $249.4 million for FY2024, which is 448.1% down from last year.
  • As of Q3 2025, Enovix's Common Equity stood at $297.1 million, which was up 7451.8% from $206.7 million recorded in Q2 2025.
  • In the past 5 years, Enovix's Common Equity registered a high of $428.7 million during Q3 2022, and its lowest value of $30.6 million during Q2 2021.
  • Moreover, its 5-year median value for Common Equity was $252.5 million (2023), whereas its average is $259.3 million.
  • In the last 5 years, Enovix's Common Equity surged by 130019.6% in 2022 and then crashed by 4232.31% in 2023.
  • Enovix's Common Equity (Quarter) stood at $323.7 million in 2021, then increased by 10.68% to $358.3 million in 2022, then fell by 27.12% to $261.1 million in 2023, then decreased by 4.48% to $249.4 million in 2024, then increased by 19.13% to $297.1 million in 2025.
  • Its Common Equity stands at $297.1 million for Q3 2025, versus $206.7 million for Q2 2025 and $237.8 million for Q1 2025.